HomeQuestion

How do you approach worsening memory loss in patients with GCA?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you approach a patient with high CRP, rising liver enzymes and new biopsy proven liver granulomas 6 months after starting methotrexate and Rituximab therapy for ANCA vasculitis?

1 Answers

Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?

2 Answers

How would you approach management of a young woman referred for isolated anterior uveitis (now resolved), in the absence of systemic manifestations or end-organ involvement, but with serologies notable for strongly positive PR3 (negative c-ANCA)?

11 Answers

How would you approach induction therapy for EGPA with neurological involvement in a middle-aged patient with foot drop and axonal peripheral neuropathy on EMG, but otherwise no evidence of GI/renal/cardiovascular involvement?

How do you go about transitioning to maintenance therapy for EGPA?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service